|
2024
|
G/S
|
Pharmaceutical preparations for use as a hemostatic agent |
|
2020
|
G/S
|
Hormonal preparation for medicinal use |
|
|
G/S
|
Pharmaceutical preparations for the treatment of endocrine diseases and disorders |
|
2017
|
G/S
|
Human pharmaceutical preparations, namely, hemostatic agents; syringes sold filled with pharmaceu... |
|
|
G/S
|
Human pharmaceutical preparations, namely, hemostatic agents |
|
2013
|
G/S
|
PHARMACEUTICAL PREPARATIONS, NAMELY, A PROSTAGLANDIN AND ACCOMPANYING INJECTION DEVICES SOLD AS A... |
|
2012
|
G/S
|
Pharmaceutical preparation, namely a tranquilizer. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of anti-inflammatory diseases, auto-immune diseases... |
|
2010
|
Invention
|
D]pyrimidin-5-yl) piperidine-4-carboxylic acid and salts thereof. The present invention comprises... |
|
|
Invention
|
Platform antibody compositions.
The present invention provides novel compositions of human IgG2 ... |
|
|
G/S
|
Pharmaceutical preparations including pharmaceuticals sold in multi compartmental vials. Multi co... |
|
|
Invention
|
Anti-bacterial vaccine compositions.
Gram negative bacterial virulence genes are identified, the... |
|
2009
|
Invention
|
Crystalline pyrazoles.
The present invention relates to crystal forms of 4-[5-(4-fluorophenyl)-3... |
|
2007
|
Invention
|
Fusion protein of exendin-4 to a transferrin (tf) polypeptide. The invention provides fusion prot... |
|
|
Invention
|
Pyridine [3,4-b] pyrazinones. Compounds and pharmaceutically acceptable salts of the compounds ar... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes. |
|
2006
|
Invention
|
Hydroxy alkyl amines.
Disclosed are compounds of formula X,
which are useful in treating A... |
|
|
Invention
|
Pyrrole substituted 2-indolinone protein kinase inhibitors. The present invention relates to pyrr... |
|
|
Invention
|
Pyridoyrazinones as pde-5 inhibitors. Compounds, and pharmaceutically acceptable salts of the com... |
|
|
Invention
|
Cannabinoid receptor ligands and uses thereof. Compounds of Formula (I) that act as cannabinoid r... |
|
|
Invention
|
Stereoselective synthesis of 3,4-disubstituted cyclopentanones and related compounds. Metho... |
|
|
Invention
|
Stereoselective synthesis of 3,4-disubstituted cyclopentanones and related compounds. Methods and... |
|
|
Invention
|
Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents. The pres... |
|
|
Invention
|
Oxazolidinones containing azetidine as antibacterial agents. The present invention provides a com... |
|
|
Invention
|
Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents. Th... |
|
|
Invention
|
Oxazolidiones containing cyclobutane as antibacterial agents. The present invention provides a co... |
|
|
Invention
|
Homomorpholine oxazolidinones as antibacterial agents. The present invention provides a com... |
|
|
Invention
|
Homomorpholine oxazolidinones as antibacterial agents. The present invention provides a compound ... |
|
|
Invention
|
Pyridine [3,4-b] pyrazinones as pde-5 inhibitors. Compounds, tautomers of the compounds, an... |
|
|
Invention
|
Pyridino ⏧2 , 3-b] pyrazinones as pde-5 inhibitors. Compounds of Formula (I), wherein R2, Y6... |
|
|
Invention
|
Pyridine ⏧3,4-b] pyrazinones as pde-5 inhibitors. Compounds, tautomers of the compounds, and... |
|
|
Invention
|
Pyridine ⏧3 , 4-b] pyrazinone compounds as pde-5 inhibitors. Compounds, tautomers of the com... |
|
|
Invention
|
Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines.
|
|
|
Invention
|
Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines. Th... |
|
|
Invention
|
An oxindole oxazolidinone as antibacterial agent. The present invention provides a compound... |
|
|
Invention
|
7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents. The present invent... |
|
|
Invention
|
An oxindole oxazolidinone as antibacterial agent. The present invention provides a compound of fo... |
|
|
Invention
|
7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents. The present invention pr... |
|
|
Invention
|
4-piperazinylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors. Compou... |
|
|
Invention
|
4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors. Compo... |
|
|
Invention
|
4-piperazinylthieno ⏧2, 3-d] pyrimidine compounds as platelet aggregation inhibitors. Compou... |
|
|
Invention
|
4-piperazinylthieno ⏧2,3-d] pyrimidine compounds as platelet aggregation inhibitors. Compoun... |
|
|
Invention
|
4-piperazinothieno ⏧2, 3-d] pyrimidine compounds as platelet aggregation inhibitors. Compoun... |
|
|
Invention
|
4-piperazinothieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors. Compou... |
|
|
Invention
|
4-piperazinnylthieno ⏧2,3-d] pyrimidine compounds as platelet aggregation inhibitors. Compou... |
|
|
Invention
|
4-piperazinnylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors. Compo... |
|
|
Invention
|
Preparation of optically pure beta-amino acids having affinity for the alpha-2-delta protein.
|
|
|
Invention
|
Preparation of optically pure beta-amino acids having affinity for the alpha-2-delta protein. Dis... |
|
|
Invention
|
M-csf antibody compositions having reduced levels of endotoxin.
The present invention provides f... |
|
|
Invention
|
Anti-m-csf antibody compositions having reduced levels of endotoxin. The present invention ... |
|
|
Invention
|
Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a che... |
|
|
Invention
|
Anti-m-csf antibody compositions having reduced levels of endotoxin. The present invention provid... |
|
|
Invention
|
Anti-madcam antibody compositions. The present invention relates to anti-MAdCAM antibody composit... |
|
|
Invention
|
Anti-madcam antibody compositions. The present invention relates to anti-MAdCAM antibody co... |
|
|
Invention
|
Composition comprising human igg2 antibody and chelating agent. The present invention provi... |
|
|
G/S
|
PHARMACEUTICALS IN THE NATURE OF AN INJECTABLE CONTRACEPTIVE AND TREATMENT FOR ENDOMETRIOSIS |
|
2005
|
G/S
|
Pharmaceutical preparation for use in the treatment of rheumatic polyarthritis and ulcerative col... |
|
|
G/S
|
Sterile surgical sponges |
|
2004
|
G/S
|
Pharmaceuticals in the nature of an injectable contraceptive and treatment for endometriosis |
|
|
Invention
|
Hydroxypropyl amides for the treatment of alzheimer's disease.
The present invention relates to... |
|
2003
|
G/S
|
Pharmaceutical preparation; namely a progestational agent |
|
|
G/S
|
Computer software for entering new medical patient data into a database containing pre-recorded m... |
|
|
G/S
|
Pharmaceutical and veterinary preparations excluding cardiovascular preparations; sanitary prepar... |
|
|
G/S
|
Pharmaceutical preparations; sanitary preparations for medical purposes; dietetic substances adap... |
|
|
G/S
|
Marketing of scientific research and scientific work. Promotion of scientific research and scient... |
|
|
G/S
|
HYPOCHOLESTEREMIC AGENT |
|
|
G/S
|
PHARMACEUTICALS FOR USE AS GROWTH HORMONE ANTAGONISTS |
|
|
G/S
|
[ Printed publications, namely, books, [ journals, ] newsletters [ and magazines ] containing med... |
|
2002
|
G/S
|
Pharmaceutical products, namely oral contraceptives |
|
|
G/S
|
Medicinal progestational preparations |
|
|
G/S
|
Pharmaceutical preparations useful as an antagonist of aldosterone particularly for use as an ant... |
|
2001
|
G/S
|
Pharmaceutical preparations for the treatment of arthritis, pain, dysmenorrhea; pharmaceutical pr... |
|
|
G/S
|
Contract manufacturing services |
|
|
G/S
|
Pharmaceuticals. Medical devices in the nature of a drug delivery system, in class 10. |
|
|
G/S
|
Pharmaceuticals, except for the treatment of hair. Medical devices in the nature of a drug delive... |
|
|
G/S
|
Pharmaceutical preparations and substances, medicines, vaccines and sera in class 5. Medical devi... |
|
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use... |
|
|
G/S
|
Pharmaceutical preparations and substances, medicines, vaccines and sera, in class 5; but not inc... |
|
2000
|
Invention
|
Tablet formation. Disclosed is a non-sustained release pharmaceutical tablet composition which co... |
|
1996
|
G/S
|
pharmaceuticals for use as growth hormone antagonists |
|
1995
|
G/S
|
pharmaceutical preparations, namely, antitumoral preparations |
|
1994
|
G/S
|
Pharmaceutical preparation; namely, an anti-arrhythmic agent. |
|
1993
|
G/S
|
pharmaceutical preparation; namely, an anti-arrhythmic agent |
|
|
G/S
|
Multi-compartment vial sold with pharmaceutical preparations therein. |
|
1992
|
G/S
|
pharmaceutical preparation; namely, a prostaglandin |
|
|
G/S
|
cardioprotective pharmaceutical for treating anthracycline induced cardiotoxicity |
|
|
G/S
|
Pharmaceutical preparation, namely a progestational agent. |
|
1991
|
G/S
|
Pharmaceuticals, namely antibiotics. |
|
|
G/S
|
pharmaceuticals; namely, antibiotics |
|
|
G/S
|
pharmaceutical preparation; namely, an antidiabetic agent |
|
1990
|
G/S
|
Pharmaceuticals for a cardioprotective product to treat anthracycline induced cardiotoxicity. |
